What changed
Q2 FY26 adjusted EPS of $1.34 rose from $1.26 YoY, but no consensus was provided. Revenue was $394M, down 2.2% from $403M in Q2 FY25. FY26 adjusted EPS guidance was lowered to $1.60-$2.00, with Q3 FY26 adjusted EPS guided to -$1.40 to -$1.20. Softness at Lilly Pulitzer and other portfolio brands offset low-single-digit comparable sales growth at Tommy Bahama.
Why it matters
Q2 FY26 adjusted EPS of $1.34 rose from $1.26 YoY, but no consensus was provided. Revenue was $394M, down 2.2% from $403M in Q2 FY25. FY26 adjusted EPS guidance was lowered to $1.60-$2.00, with Q3 FY26 adjusted EPS guided to -$1.40 to -$1.20. Softness at Lilly Pulitzer and other portfolio brands offset low-single-digit comparable sales growth at Tommy Bahama.